Switching from branded alendronate or risedronate to generic alendronate: Effect on persistence with bisphosphonate therapy in Germany

Autor:	K. Schüssel, P. Hadji, D. Klöckner, S. Czeche, V. Ziller, R. Quinzler, W. Moehrke, A. Franzmann, M. Schulz
Rok vydání:	2009
Předmět:	Oncology medicine.medical_specialty Histology Physiology business.industry Endocrinology Diabetes and Metabolism Internal medicine medicine Bisphosphonate therapy business Persistence (computer science)
Zdroj:	Bone. 44:S449-S450
ISSN:	8756-3282
DOI:	10.1016/j.bone.2009.03.423
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c760bdcdfe46b15c1097bc9705abaf75 https://doi.org/10.1016/j.bone.2009.03.423 Zobrazit plný text záznamu Full Text from ScienceDirect